Piessevaux, H., Buyse, M., Schlichting, M., Van Cutsem, E., Bokemeyer, C., Heeger, S., & Tejpar, S. (2013). Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab. Journal of clinical oncology, 31(30), 3764. https://doi.org/10.1200/JCO.2012.42.8532
Citace podle Chicago (17th ed.)Piessevaux, Hubert, Marc Buyse, Michael Schlichting, Eric Van Cutsem, Carsten Bokemeyer, Steffen Heeger, a Sabine Tejpar. "Use of Early Tumor Shrinkage to Predict Long-term Outcome in Metastatic Colorectal Cancer Treated with Cetuximab." Journal of Clinical Oncology 31, no. 30 (2013): 3764. https://doi.org/10.1200/JCO.2012.42.8532.
Citace podle MLA (9th ed.)Piessevaux, Hubert, et al. "Use of Early Tumor Shrinkage to Predict Long-term Outcome in Metastatic Colorectal Cancer Treated with Cetuximab." Journal of Clinical Oncology, vol. 31, no. 30, 2013, p. 3764, https://doi.org/10.1200/JCO.2012.42.8532.